Saranas, Inc., a privately held medical device company focusing on improving patient outcomes through early detection and monitoring of internal bleeding complications, has announced a US$12.8 million Series B investment led by Baird Capital, the venture capital and global private equity arm of Baird. Baird Capital was joined in the investment by Austin, Texas-based S3 Ventures.

Latham & Watkins LLP represents Baird Capital in the transaction with an emerging companies team led by Boston partner Evan Smith, with New York associate Teddy Ellison. Boston partner Hans Brigham provided additional advice on corporate matters.